{
  "symbol": "ZTS",
  "year": 2023,
  "competition_summary": [
    {
      "competitor": "Environmental, Health and Safety 14 Available Information",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Mine Safety Disclosures",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Registrant\u2019s Common Equity",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Issuer Purchases of",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Management\u2019s Discussion and Analysis of Financial Condition",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Financial Statements",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Procedures",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Security Ownership of Certain Beneficial Owners and Management",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Overview Zoetis Inc.",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Pfizer Inc.",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Zoetis Inc.",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "\u2022 International",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Client Supply Services",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "CSS",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Management's Discussion and Analysis of Financial Condition",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Consolidated Financial Statements",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Segment Information",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "BRD",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Spectramast \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "the European Union",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "EU",
      "mentions": 7,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "\u2022 Core EQ",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Eastern",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Fostera Gold PCV MH",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Fostera/Suvaxyn \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "\u2022 Poulvac \u00ae Procerta",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "HVT",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Marek",
      "mentions": 3,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Poulvac Procerta HVT-IBD",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Poulvac Procerta HVT-ND",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Poulvac Procerta HVT-IBD-ND",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "ProHeart",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "\u2022 Protivity \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "\u2022 Solensia TM",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "European Commission",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Vanguard",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Vanguard CIV H3N2/H3N8",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Bordetella bronchiseptica",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "CIRDC",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Texas A&M University",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "FMD",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Colorado State University",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Pharmaq",
      "mentions": 3,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Alpha Ject Micro 1",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "TiLa",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Alpha Ject Micro 1 Si",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Alpha Ject Micro 4-2",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Alpha Flux \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "control sea",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Zoetis",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Fish Vet Group",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Abaxis, Inc.",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Phoenix Central Laboratory for Veterinarians, Inc.",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "LLC",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Ethos Diagnostic Science",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "ProFlok \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Vetscan Imagyst",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Imagyst",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "AI",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Platinum Performance",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Basepaws",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Simparica/Simparica Trio",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Description Primary",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Lyme",
      "mentions": 2,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Bordatella bronchiseptica Dogs Anti-infectives",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Clavamox \u00ae /",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Parasiticides ProHeart \u00ae Prevents",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Dogs Other Pharmaceutical Products Cerenia",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "age Dogs Animal Health Diagnostics VetScan \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Vaccines Improvac \u00ae / Improvest \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Swine Rispoval \u00ae /",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "BVD",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Cattle Suvaxyn \u00ae",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Draxxin KP/Draxxin Plus",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Ketoprofen",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Spectramast \u00ae Treatment",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Cattle Parasiticides Dectomax \u00ae Injectable",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    },
    {
      "competitor": "Cattle",
      "mentions": 1,
      "context": "Competition 8 Intellectual Property 9 Regulatory 9 Human Capital Management 11 Information about our Executive Officers 13 Environmental, Health and Safety 14 Available Information 15 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 28 Item 2. Properties 28 Item 3. Legal Proceedings 28 Item 4. Mine Safety Disclosures 28 PART II Item 5. Market for Registrant\u2019s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 7. Management\u2019s Discussion and Ana"
    }
  ]
}